Director/PDMR Shareholding
July 23 2010 - 11:10AM
UK Regulatory
TIDMGWP
RNS Number : 8719P
GW Pharmaceuticals PLC
23 July 2010
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 23 July 2010: GW Pharmaceuticals (AIM: GWP) hereby provides
notification that the Company has today been notified that Richard Forrest,
non-executive Director, has today purchased 20,000 ordinary shares of 0.1p each
at the market price of 109 pence per share. This purchase equates to 0.015% of
the issued ordinary share capital.
Following this notification Richard Forrest's beneficial interest has increased
to 60,000 ordinary shares, amounting to 0.046% of the shares in issue.
The total number of shares outstanding in the Company is 130,041,372 ordinary
shares of 0.1p each.
For further information, please contact:
GW Pharmaceuticals PLC +44
(0)1980 557 000
Adam George, Company Secretary
Piper Jaffray Ltd (Nominated Adviser)
Neil Mackison/Rupert Winckler +44 (0)
203 142 8700
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFIRDAIVFII
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles